Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 1 13Phase 3 9Phase 1/2 5Phase 4 4Phase NA 1Phase EARLY_PHASE1 1

Status

Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4

Conditions

Ovarian Neoplasms 4Carcinoma, Ovarian Epithelial 1

Interventions

niraparib 4olaparib 2apatinib 2Sevoflurane 2Saline Solution 2Propofol 2Carboplatin 2Bevacizumab 2pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1pazopanib 1palbociclib 1liposomal doxorubicin 1lenvatinib 1gadofosveset trisodium 1fosaprepitant 1ferrous fumarate 1Tranexamic Acid 1Trabectedin 1Sunitinib 1Sodium Chloride 1Pharmacokinetics 1Patient-Specific Modeling 1Pafolacianine 1Paclitaxel 1LY 353381 1Injections 1Indocyanine Green 1Folic Acid 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Ovarian Neoplasms × niraparib × Clear all
NCT06412120 2026-04-23

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

University of Miami

Phase 4 Recruiting
70 enrolled
Gynecologic

Ovarian Neoplasms

NCT06887933 2025-03-21

A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

GlaxoSmithKline

Phase 4 Not yet recruiting
67 enrolled
Gynecologic

Ovarian Neoplasms

NCT03752216 2024-12-13

NiQoLe

ARCAGY/ GINECO GROUP

Phase 4 Completed
141 enrolled
Gynecologic

Ovarian Neoplasms

NCT05187208 2022-01-26

POLO

Seoul National University Hospital

Phase 4 Unknown
102 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡